Clinical Trials in Veterinary Medicine: A New Era Brings New Challenges
暂无分享,去创建一个
S S Ellenberg | S. Ellenberg | P. Shaw | M. Oyama | M A Oyama | P A Shaw
[1] W. Sischo,et al. A Randomized Clinical Trial Evaluating the Effects of Oligosaccharides on Transfer of Passive Immunity in Neonatal Dairy Calves , 2016, Journal of veterinary internal medicine.
[2] Ravi Varadhan,et al. Evaluating Health Outcomes in the Presence of Competing Risks: A Review of Statistical Methods and Clinical Applications , 2010, Medical care.
[3] M. Pencina,et al. General Cardiovascular Risk Profile for Use in Primary Care: The Framingham Heart Study , 2008, Circulation.
[4] Kathryn C. Loeser,et al. Intention-to-treat and transparency of related practices in randomized, controlled trials of anti-infectives , 2016, BMC Medical Research Methodology.
[5] M. Laakso,et al. Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial , 2006, The Lancet.
[6] G. Guyatt,et al. Methodologic discussions for using and interpreting composite endpoints are limited, but still identify major concerns. , 2007, Journal of clinical epidemiology.
[7] Joel Huber,et al. Weighting composite endpoints in clinical trials: essential evidence for the heart team. , 2012, The Annals of thoracic surgery.
[8] J. Valcour,et al. Quality of reporting of clinical trials of dogs and cats and associations with treatment effects. , 2010, Journal of veterinary internal medicine.
[9] Sylvie Chabaud,et al. Experimental designs for small randomised clinical trials: an algorithm for choice , 2013, Orphanet Journal of Rare Diseases.
[10] J. Heller. Epidemiological and statistical considerations for interpreting and communicating oncology clinical trials. , 2015, Veterinary journal.
[11] J. Sargeant,et al. The REFLECT Statement: Reporting Guidelines for Randomized Controlled Trials in Livestock and Food Safety: Explanation and Elaboration † , 2010, Journal of food protection.
[12] Jeroen J. Bax,et al. Traditional and new composite endpoints in heart failure clinical trials: facilitating comprehensive efficacy assessments and improving trial efficiency , 2016, European journal of heart failure.
[14] D. Kent,et al. Reporting clinical trial results to inform providers, payers, and consumers. , 2005, Health affairs.
[15] J. Bonagura,et al. Acute Effects of Ivabradine on Dynamic Obstruction of the Left Ventricular Outflow Tract in Cats with Preclinical Hypertrophic Cardiomyopathy , 2014, Journal of veterinary internal medicine.
[16] S. Pocock,et al. Challenging Issues in Clinical Trial Design: Part 4 of a 4-Part Series on Statistics for Clinical Trials. , 2015, Journal of the American College of Cardiology.
[17] D. Kent,et al. Competing risk and heterogeneity of treatment effect in clinical trials , 2008, Trials.
[18] P. Fox,et al. Long‐term Outcome of Irish Wolfhound Dogs with Preclinical Cardiomyopathy, Atrial Fibrillation, or Both Treated with Pimobendan, Benazepril Hydrochloride, or Methyldigoxin Monotherapy , 2016, Journal of veterinary internal medicine.
[19] N. Di Girolamo,et al. Deficiencies of effectiveness of intervention studies in veterinary medicine: a cross-sectional survey of ten leading veterinary and medical journals , 2016, PeerJ.
[20] Nick Freemantle,et al. Composite outcomes in randomized trials: greater precision but with greater uncertainty? , 2003, JAMA.
[21] David Moher,et al. CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials. , 2010, Obstetrics and gynecology.
[22] Anna C. Balazs,et al. Influence of adherence to treatment and response of cholesterol on mortality in the coronary drug project. , 1980, The New England journal of medicine.
[23] M. Giuffrida. Defining the primary research question in veterinary clinical studies. , 2016, Journal of the American Veterinary Medical Association.
[24] Ê. Ferreira,et al. Quantitation of the Regional Lymph Node Metastatic Burden and Prognosis in Malignant Mammary Tumors of Dogs , 2015, Journal of veterinary internal medicine.
[25] Scoring System for Multiple Organ Dysfunction in Adult Horses with Acute Surgical Gastrointestinal Disease , 2016, Journal of veterinary internal medicine.
[26] S. Shapiro,et al. The intention-to-treat approach in randomized controlled trials: Are authors saying what they do and doing what they say? , 2007, Clinical trials.
[27] M. Giuffrida. Type II error and statistical power in reports of small animal clinical trials. , 2014, Journal of the American Veterinary Medical Association.
[28] I R Dohoo,et al. The REFLECT statement: reporting guidelines for randomized controlled trials in livestock and food safety: explanation and elaboration. , 2010, Journal of food protection.
[29] Mohammad Mahdi Jalali,et al. Effect of a Probiotic on Prevention of Diarrhea and Clostridium difficile and Clostridium perfringens Shedding in Foals , 2015, Journal of veterinary internal medicine.
[30] N. Cohen,et al. Gallium Maltolate as an Alternative to Macrolides for Treatment of Presumed Rhodococcus equi Pneumonia in Foals , 2015, Journal of veterinary internal medicine.
[31] David M Kent,et al. Assessing and reporting heterogeneity in treatment effects in clinical trials: a proposal , 2010, Trials.
[32] D. M. Hassel,et al. Clinical features and prognostic variables in 109 horses with esophageal obstruction (1992-2009). , 2010, Journal of veterinary internal medicine.
[33] R. Kruse,et al. Intention-to-treat analysis: who is in? Who is out? , 2002, The Journal of family practice.
[34] A. Detsky,et al. Composite end points in randomized trials: there is no free lunch. , 2010, JAMA.
[35] David L. DeMets,et al. Data Monitoring Committees in Clinical Trials , 2002 .
[36] J. McMurray,et al. Statistical Controversies in Reporting of Clinical Trials: Part 2 of a 4-Part Series on Statistics for Clinical Trials. , 2015, Journal of the American College of Cardiology.
[37] J. Wofford,et al. A Prospective, Randomized, Masked, Placebo‐Controlled Multisite Clinical Study of Grapiprant, an EP4 Prostaglandin Receptor Antagonist (PRA), in Dogs with Osteoarthritis , 2016, Journal of veterinary internal medicine.
[38] J. Ball,et al. Statistics review 12: Survival analysis , 2004, Critical care.
[39] P. O'Brien,et al. A multiple testing procedure for clinical trials. , 1979, Biometrics.
[40] J. Häggström,et al. Survival characteristics and prognostic variables of dogs with preclinical chronic degenerative mitral valve disease attributable to myxomatous degeneration. , 2012, Journal of veterinary internal medicine.
[41] J. Wofford,et al. A Prospective, Randomized, Masked, Placebo‐Controlled Clinical Study of Capromorelin in Dogs with Reduced Appetite , 2016, Journal of veterinary internal medicine.
[42] Gordon H Guyatt,et al. Problems with use of composite end points in cardiovascular trials: systematic review of randomised controlled trials , 2007, BMJ : British Medical Journal.
[43] J. PérezMartín,et al. [International Committee of Medical Journal Editors]. , 2008, Revista alergia Mexico.
[44] M. Chigerwe,et al. A Randomized Clinical Trial Evaluating Metabolism of Colostral and Plasma Derived Immunoglobulin G in Jersey Bull Calves , 2015, Journal of veterinary internal medicine.
[45] D. Moher,et al. CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials , 2010, Journal of clinical epidemiology.
[46] Shiliang Huang,et al. NF-κB-Dependent Upregulation of NCX1 Induced by Angiotensin II Contributes to Calcium Influx in Rat Aortic Smooth Muscle Cells. , 2016, The Canadian journal of cardiology.
[47] K. Muñana,et al. A Placebo‐Controlled, Prospective, Randomized Clinical Trial of Polyethylene Glycol and Methylprednisolone Sodium Succinate in Dogs with Intervertebral Disk Herniation , 2015, Journal of veterinary internal medicine.
[48] J. Elliott,et al. The combined prognostic potential of serum high-sensitivity cardiac troponin I and N-terminal pro-B-type natriuretic peptide concentrations in dogs with degenerative mitral valve disease. , 2012, Journal of veterinary internal medicine.
[49] Ewout W Steyerberg,et al. Competing risks and the clinical community: irrelevance or ignorance? , 2011, Statistics in medicine.
[50] C. Rodriguez,et al. Randomized Phase III Trial of Piroxicam in Combination with Mitoxantrone or Carboplatin for First‐Line Treatment of Urogenital Tract Transitional Cell Carcinoma in Dogs , 2015, Journal of veterinary internal medicine.
[51] Patrick Royston,et al. Designs for clinical trials with time-to-event outcomes based on stopping guidelines for lack of benefit , 2011, Trials.
[52] David M Kent,et al. Limitations of applying summary results of clinical trials to individual patients: the need for risk stratification. , 2007, JAMA.
[53] John Hoey,et al. Clinical trial registration: a statement from the International Committee of Medical Journal Editors. , 2004, JAMA.
[54] E. Skjerve,et al. Effect of Ovariohysterectomy at the Time of Tumor Removal in Dogs with Mammary Carcinomas: A Randomized Controlled Trial , 2015, Journal of veterinary internal medicine.
[55] K. Muñana,et al. Effect of Cranberry Extract on the Frequency of Bacteriuria in Dogs with Acute Thoracolumbar Disk Herniation: A Randomized Controlled Clinical Trial , 2016, Journal of veterinary internal medicine.
[56] Viv Bewick,et al. Statistics review 11: Assessing risk , 2004, Critical care.
[57] H. Weng,et al. Secondary prevention of cardiogenic arterial thromboembolism in the cat: The double-blind, randomized, positive-controlled feline arterial thromboembolism; clopidogrel vs. aspirin trial (FAT CAT). , 2015, Journal of veterinary cardiology : the official journal of the European Society of Veterinary Cardiology.
[58] J. Lau,et al. The impact of high-risk patients on the results of clinical trials. , 1997, Journal of clinical epidemiology.
[59] J. Elliott,et al. The Effect of Moderate Dietary Protein and Phosphate Restriction on Calcium‐Phosphate Homeostasis in Healthy Older Cats , 2016, Journal of veterinary internal medicine.
[60] J. Elliott,et al. Comparison of Efficacy of Long‐term Oral Treatment with Telmisartan and Benazepril in Cats with Chronic Kidney Disease , 2015, Journal of veterinary internal medicine.
[61] Lisa M. Schwartz,et al. Definition, reporting, and interpretation of composite outcomes in clinical trials: systematic review , 2010, BMJ : British Medical Journal.
[62] J M Lachin,et al. Statistical considerations in the intent-to-treat principle. , 2000, Controlled clinical trials.
[63] K. Anstrom,et al. Composite End Points in Acute Heart Failure Research: Data Simulations Illustrate the Limitations. , 2016, The Canadian journal of cardiology.
[64] Kurt Lohman,et al. Interpreting measures of treatment effect in cancer clinical trials. , 2002, The oncologist.
[65] P Glasziou,et al. Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial , 2005, The Lancet.
[66] M. L. O’Sullivan,et al. Efficacy of Pimobendan in the Prevention of Congestive Heart Failure or Sudden Death in Doberman Pinschers with Preclinical Dilated Cardiomyopathy (The PROTECT Study) , 2012, Journal of veterinary internal medicine.
[67] M. L. O’Sullivan,et al. Effect of Pimobendan in Dogs with Preclinical Myxomatous Mitral Valve Disease and Cardiomegaly: The EPIC Study—A Randomized Clinical Trial , 2016, Journal of veterinary internal medicine.
[68] L. Duchateau,et al. Clinical, Pathologic, and Immunohistochemical Prognostic Factors in Dogs with Thyroid Carcinoma , 2014, Journal of veterinary internal medicine.
[69] U. Dafni,et al. Informed Choice of Composite End Points in Cardiovascular Trials , 2014, Circulation. Cardiovascular quality and outcomes.
[70] B. Meij,et al. The Prognostic Value of Perioperative Profiles of ACTH and Cortisol for Recurrence after Transsphenoidal Hypophysectomy in Dogs with Corticotroph Adenomas , 2015, Journal of veterinary internal medicine.
[71] J. Bland,et al. Efficacy of spironolactone on survival in dogs with naturally occurring mitral regurgitation caused by myxomatous mitral valve disease. , 2010, Journal of veterinary internal medicine.
[72] S. Buczinski,et al. Preoperative and Postoperative L‐Lactatemia Assessment for the Prognosis of Right Abomasal Disorders in Dairy Cattle , 2014, Journal of veterinary internal medicine.
[73] D. Werling,et al. A Prospective, Randomized, Blinded, Placebo‐Controlled Pilot Study on the Effect of Enterococcus faecium on Clinical Activity and Intestinal Gene Expression in Canine Food‐Responsive Chronic Enteropathy , 2015, Journal of veterinary internal medicine.
[74] John Hoey,et al. Clinical trial registration: a statement from the International Committee of Medical Journal Editors. , 2005, Circulation.
[75] M. Faires,et al. Reporting of methodological features in observational studies of pre-harvest food safety. , 2011, Preventive veterinary medicine.
[76] M. Gail,et al. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. , 1989, Journal of the National Cancer Institute.
[77] R. Brian Haynes,et al. Forming research questions☆ , 2006, Journal of Clinical Epidemiology.
[78] E. Cobo,et al. Discordance between reported intention-to-treat and per protocol analyses. , 2007, Journal of clinical epidemiology.
[79] J. Häggström,et al. Effect of pimobendan or benazepril hydrochloride on survival times in dogs with congestive heart failure caused by naturally occurring myxomatous mitral valve disease: the QUEST study. , 2008, Journal of veterinary internal medicine.
[80] William White,et al. A Proposal , 2008, Moon, Sun, and Witches.
[81] J. Elliott,et al. Randomized Placebo‐Controlled Clinical Trial of a Chewable Formulation of Amlodipine for the Treatment of Hypertension in Client‐Owned Cats , 2015, Journal of veterinary internal medicine.